Intravenous cocaine self-administration in mice lacking 5-HT1B receptors

Pharmacology Biochemistry and Behavior

Volumn 57, Issue 3, 1997, Pages 407-412

  Rocha, Beatriz A ^a   Ator, Robert ^a   Emmett Oglesby, Michael W ^a   Hen, Rene ^b  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b The New York Presbyterian Hospital   (United States)

Author keywords

5 HT1B receptors; Cocaine; IV self administration; Reinforcing effects; Transgenic mice

Indexed keywords

COCAINE; SEROTONIN 1B RECEPTOR;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; TRANSGENIC MOUSE;

ANIMALS; COCAINE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, SEROTONIN; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

MUS MUSCULUS;

EID: 0030814702     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00444-3     Document Type: Article

References (59)

1. Aghajanian G. K., Bunney B. S. Dopaminergic and non-dopaminergic neurons of the substantia nigra. Differential responses to putative transmitters Boissier:1975;9th. J. R.; Hippius, H.; Pichot, P., eds. Proceedings of the International Congress of the Collegium Internationale Neuropsychopharmacologicum. Amsterdam: Excerpta Medica Foundation;:444-452.
2. Bozarth M. A., Murray A., Wise R. A. Influence of housing conditions on the acquisition of intravenous heroin and cocaine self-administration in rats. Pharmacol. Biochem. Behav. 33:1989;903-907.
3. Buhot M.-C., Ait-Amara D., Hen R., Segu L. Do 5-HT1B receptors play a role in behavioral inhibition? An explorer mutant mouse story. Soc. Neurosci. Abstr. 21:1995;267.
4. Caine S. B., Gold L. H., Koob G. F., Deroche V., Heyser C., Polis I., Roberts A., Xu M., Tonegawa S. Intravenous cocaine self-administration in mice. Strain differences and effects of D-1 dopamine receptor targeted gene mutation Soc. Neurosci. Abstr. 21:1995;719.
5. Callahan P. M., Cunningham K. A. Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors. J. Pharmacol. Exp. Ther. 274:1995;1414-1424.
6. Cameron D. L., Williams J. T. Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J. Neurosci. 14:1994;6763-6767.
7. Carney J. M., Landrum R. W., Cheng M. S., Seale T. W. Establishment of chronic intravenous drug self-administration in the C57BL/6J mouse. NeuroReport. 2:1991;477-480.
8. Carroll M. E., Lac S. T., Asencio M., Kragh R. Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan. Psychopharmacology. 100:1990;293-300.
9. Carroll M. E., Lac S. T., Asencio M., Kragh R. Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 35:1990;237-244.
10. Davidson E. S., Funch J. F., Schenk S. Variability in subjective responses to cocaine. Initial experiences of college students Addict. Behav. 18:1993;445-453.
11. Dray A., Davies J., Oakley N. R., Tongotroach P., Velluci S. The dorsal and medial raphe projections to the substantia nigra in the rat. Electrophysiological, biochemical and behavioural observations Brain Res. 151:1978;431-442.
12. Emmett-Oglesby M. W., Wurst M. F., Lal H. Discriminative stimulus properties of small dose of cocaine. Neuropharmacology. 22:1983;97-101.
13. Furth P. A., St. Onge L., Boger H., Gruss P., Gossen M., Kistner A., Hennighausen L. Temporal control of gene expression in transgenic mice by a tetracycline responsive promoter. Proc. Natl. Acad. Sci. USA. 91:1994;9302-9306.
14. Gawin F. H. Cocaine addiction. Psychology and neurophysiology Science. 251:1991;1580-1586.
15. Grahame N. J., Phillips T. J., Burkhart-Kasch S., Cunningham C. L. Intravenous cocaine self-administration in the C57BL/6J mouse. Pharmacol. Biochem. Behav. 51:1995;827-834.
16. Guan X. M., McBride W. J. Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res. Bull. 23:1989;541-547.
17. Hartig P. R., Brancheck T. A., Weishank R. L. A subfamily of 5-HT1D receptor genes. Trends Pharmacol. Sci. 13:1992;152-159.
18. Horger B. A., Shelton K., Schenk S. Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol. Biochem. Behav. 37:1990;707-711.
19. Hoyer D., Clarke D. E., Fozard J. R. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
20. Johanson C. E., Fischman M. W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41:1989;3-52.
21. Kalivas P. W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev. 18:1993;75-113.
22. Kalivas P. W., Weber B. Role of the A10 dopamine neurons in sensitization to cocaine and amphetamine. Soc. Neurosci. Abstr. 13:1987;600.
23. Katz J. L. Models of relative reinforcing efficacy of drugs and their predictive utility. Behav. Pharmacol. 1:1990;283-301.
24. Koob G. F., Bloom F. E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
25. Koob G. F., Le H. T., Creese I. The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci. Lett. 79:1987;315-320.
26. Kuhar M. J., Ritz M. C., Boja J. W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14:1991;299-302.
27. Loh E. A., Roberts D. C. S. Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology. 110:1990;262-266.
28. Meisch R. A., Lemaire G. A. Oral self-administration of pentobarbital by rhesus monkeys. Maintenance of behavior by different concurrently available volumes of drug solution J. Exp. Anal. Behav. 52:1989;111-126.
29. Modell J. G., Tandon R., Beresford T. P. Dopaminergic activity of the antihistaminic antiparkinsonian agents. J. Clin. Psychopharmacol. 9:1989;347-351.
30. Nedergaard S., Bolam J. P., Greenfield S. A. Facilitation of dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra. Nature. 333:1988;174-177.
31. Nicolaou N. M., Garcia-Munoz M., Arbuthnot G. W., Eccleston D. Interactions between serotonergic and dopaminergic systems in rat brain demonstrated by small unilateral lesions of the raphe nuclei. Eur. J. Pharmacol. 57:1979;295-305.
32. Nissbrandt H., Waters N., Hjorth S. The influence of serotonergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn-Schmiedebergs Arch. Pharmacol. 346:1992;12-19.
33. Peltier R., Schenk S. The effects of serotonergic manipulations on cocaine self-administration in rats. Psychopharmacology. 110:1993;390-394.
34. Peroutka S. J. Molecular biology of serotonin (5-HT) receptors. Synapse. 18:1994;241-260.
35. Piazza P. V., Deminiere J. M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science. 245:1989;1511-1513.
36. Piazza P. V., Deminiere J. M., Le Moal M., Simon H. Stress and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 514:1990;22-26.
37. Reith M. E. A., Meisler B. E., Sershen H., Lajtha A. Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem. Pharmacol. 35:1986;1123-1129.
38. 3H]cocaine binding in brain is associated with serotonin neurons. Mol. Pharmacol. 23:1983;600-606.
39. Ritz M. C., Cone E. J., Kuhar M. J. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters; a structure-activity study. Life Sci. 46:1990;635-645.
40. Roberts D. C. S. Breaking points on a progressive ratio schedule reinforced by intravenous apomorphine increase daily following 6-hydroxytryptamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 32:1989;43-47.
41. Roberts D. C. S., Bennett S. A. L., Vickers G. The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology. 98:1989;408-411.
42. Roberts D. C. S., Koob G. F. Disruption of cocaine self-administration following 6-hydroxytryptamine lesion of the ventral tegmental area in rats. Pharmacol. Biochem. Behav. 17:1982;901-904.
43. Roberts D. C. S., Loh E. A., Vickers G. Self-administration of cocaine on a progressive ratio schedule in rats. Dose-response relationship and effect of haloperidol pretreatment Psychopharmacology. 97:1989;535-538.
44. Robinson T. E., Berridge K. C. The neural basis of drug craving. An incentive-sensitization theory of addiction Brain Res. Rev. 18:1993;247-291.
45. Saudou F., Ait-Amara D., LeMeur M., Ramboz S., Segu L., Buhot M., Hen R. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science. 265:1994;1875-1878.
46. Scearce K., Castanon N., Hen R. Mice lacking 5-HT1B receptors display altered behavioral responses to cocaine. Soc. Neurosci. Abstr. 21:1995;715.
47. Schenk S., Lacelle G., Gorman K., Amit Z. Cocaine self-administration in rats influenced by environmental conditions. Implications for the etiology of drug abuse Neurosci. Lett. 81:1987;227-231.
48. Schenk S., Valadez A., McNamara C., House D., Higley D., Bankson M. T., Gibbs S., Horger B. A. Development and expression of sensitization to cocaine's reinforcing properties. Role of NMDA receptors Psychopharmacology. 111:1993;332-338.
49. Spealman R. D. Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology. 112:1993;93-99.
50. Spencer D., Emmett-Oglesby M. W. Parallel processing strategies in the application of microcomputers to behavioral laboratories. Behav. Res. Methods Instrum. 17:1985;294-300.
51. Van der Kooy D., Hattori T. Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra. A fluorescent retrograde double labeling study in the rat Brain Res. 186:1980;1-7.
52. Weeks J. Experimental morphine addiction. Method for automatic intravenous injections in unrestained rats Science. 138:1962;143-144.
53. Wilkinson, L.: SYSTAT: The system for statistics. SYSTAT, Inc., Evanston, IL; 1990.
54. Wilkinson L. O., Dourish C. T. Serotonin and animal behavior. Peroutka S. Serotonin receptor subtypes. Basic and clinical aspects:1991;147-210 John Wiley & Sons Ltd, New York.
55. Wilson M. C., Schuster C. R. Cholinergic influence on intravenous cocaine self-administration by rhesus monkeys. Pharmacol. Biochem. Behav. 1:1973;643-649.
56. Wirtshafter D., Stratford T. R., Asin K. E. Evidence that serotonergic projections to the substantia nigra in the rat arise in the dorsal, but not the median, raphe nucleus. Neurosci. Lett. 77:1987;261-266.
57. Wise R. A. Neural mechanism of the reinforcing action of cocaine. NIDA Res. Monogr. 50:1984;15-33.
58. Wise R. A., Bozarth M. A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
59. Woolverton W. L., Cervo L., Johanson C. E. Effects of repeated metamphetamine administration on metamphetamine self-administration in rhesus monkeys. Pharmacol. Biochem. Behav. 21:1984;737-741.